Universitätsklinikum Würzburg

Hospital


Location: Würzburg, Germany (DE) DE

ISNI: 0000000113787891

ROR: https://ror.org/03pvr2g57

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Quantification of left ventricular mass by echocardiography compared to cardiac magnet resonance imaging in hemodialysis patients (2020) Grebe SJ, Malzahn U, Donhauser J, Liu D, Wanner C, Krane V, Hammer F Journal article Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study (2020) Maron RC, Utikal JS, Hekler A, Hauschild A, Sattler E, Sondermann W, Haferkamp S, et al. Journal article Reconstituting NK Cells After Allogeneic Stem Cell Transplantation Show Impaired Response to the Fungal Pathogen Aspergillus fumigatus (2020) Weiss E, Schlegel J, Terpitz U, Weber M, Linde J, Schmitt AL, Huenniger K, et al. Journal article Overcoming key challenges in cancer immunotherapy with engineered T cells (2020) Arcangeli S, Mestermann K, Weber J, Bonini C, Casucci M, Hudecek M Journal article, Review article New targets and technologies for CAR-T cells (2020) Freitag F, Maucher M, Riester Z, Hudecek M Journal article, Review article Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma (2020) Beauvais D, Danhof S, Hayden PJ, Einsele H, Yakoub-Agha I Journal article, Review article The link between cytogenetics/genomics and imaging patterns of relapse and progression in patients with relapsed/refractory multiple myeloma: A pilot study utilizing 18f-fdg pet/ct (2020) Zhou X, Dierks A, Kertels O, Samnick S, Kircher M, Buck AK, Haertle L, et al. Journal article RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS (2020) Seibold M, Stuehmer T, Kremer N, Mottok A, Scholz CJ, Schlosser A, Leich E, et al. Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article Overview of the side-effects of FDA-and/or EMA-approved targeted therapies for the treatment of hematological malignancies (2020) Constantinescu C, Pasca S, Zimta AA, Tat T, Rus I, Teodorescu P, Iluta S, et al. Journal article